Literature DB >> 10490701

Physical mapping of the serotonin 5-HT(7) receptor gene (HTR7) to chromosome 10 and pseudogene (HTR7P) to chromosome 12, and testing of linkage disequilibrium between HTR7 and autistic disorder.

J P Lassig1, K Vachirasomtoon, K Hartzell, M Leventhal, E Courchesne, R Courchesne, C Lord, B L Leventhal, E H Cook.   

Abstract

The gene encoding the serotonin 5-HT(7) receptor (HTR7) has been considered as a candidate locus in several neuropsychiatric disorders, based on pharmacological evidence and ligand-binding studies. After determining over 3 kb of previously unpublished sequence from introns 1 and 2 of HTR7, a single base (C/T) polymorphism in the second intron of HTR7 was found. Allele-specific PCR was used to genotype the HTR7 marker in 53 trios consisting of subjects with autistic disorder and both parents. Using the transmission disequilibrium test (TDT), no evidence of preferential transmission of either allele was found (TDT chi(2) = 0.252, p = 0.602). Sequence data obtained from both intron 1 and intron 2 of HTR7, and from the 5-HT(7) pseudogene (HTR7P), was used to confirm localization of HTR7 to 10q23 and HTR7P to 12p13 using radiation hybrid analyses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490701     DOI: 10.1002/(sici)1096-8628(19991015)88:5<472::aid-ajmg7>3.0.co;2-g

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  11 in total

Review 1.  The pathophysiology and treatment of autism.

Authors:  D J Posey; C J McDougle
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

Review 2.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

3.  Disruption to the 5-HT7 Receptor Following Hypoxia-Ischemia in the Immature Rodent Brain.

Authors:  Julie A Wixey; Hanna E Reinebrant; Kirat K Chand; Kathryn M Buller
Journal:  Neurochem Res       Date:  2018-01-22       Impact factor: 3.996

Review 4.  The molecular genetics of autism.

Authors:  T H Wassink; J Piven
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

Review 5.  Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment.

Authors:  Ansoo Lee; Hyunah Choo; Byungsun Jeon
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

Review 6.  Autism: in search of susceptibility genes.

Authors:  Janine A Lamb; Jeremy R Parr; Anthony J Bailey; Anthony P Monaco
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

Review 7.  Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor.

Authors:  Jieon Lee; Diana Avramets; Byungsun Jeon; Hyunah Choo
Journal:  Molecules       Date:  2021-06-02       Impact factor: 4.411

8.  Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum Disorder.

Authors:  Kavita S Reddy
Journal:  BMC Med Genet       Date:  2005-01-18       Impact factor: 2.103

Review 9.  An evo-devo approach to thyroid hormones in cerebral and cerebellar cortical development: etiological implications for autism.

Authors:  Pere Berbel; Daniela Navarro; Gustavo C Román
Journal:  Front Endocrinol (Lausanne)       Date:  2014-09-09       Impact factor: 5.555

Review 10.  5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders.

Authors:  Lucia Ciranna; Maria Vincenza Catania
Journal:  Front Cell Neurosci       Date:  2014-08-27       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.